232 related articles for article (PubMed ID: 33417998)
1. Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression.
Pawluczyk IZA; Didangelos A; Barbour SJ; Er L; Becker JU; Martin R; Taylor S; Bhachu JS; Lyons EG; Jenkins RH; Fraser D; Molyneux K; Perales-Patón J; Saez-Rodriguez J; Barratt J
Kidney Int; 2021 May; 99(5):1127-1139. PubMed ID: 33417998
[TBL] [Abstract][Full Text] [Related]
2. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
Zhang M; Duan ZY; Zhang QY; Xu XG; Zhang Y; Wang P; Duan SW; Wu J; Chen XM; Cai GY
Sci Rep; 2023 Apr; 13(1):6048. PubMed ID: 37055445
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of Urinary miR-152-5p in Patients with IgA Nephropathy with Elevated Proteinuria Levels.
Duan A; Liu L; Lou Y; Zhang D; Li H; Chen Y; Cui W; Miao L
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307184
[TBL] [Abstract][Full Text] [Related]
4. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy.
Wang N; Bu R; Duan Z; Zhang X; Chen P; Li Z; Wu J; Cai G; Chen X
PeerJ; 2015; 3():e990. PubMed ID: 26056621
[TBL] [Abstract][Full Text] [Related]
5. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
Duan ZY; Bu R; Liang S; Chen XZ; Zhang C; Zhang QY; Li JJ; Chen XM; Cai GY
Front Immunol; 2024; 15():1326026. PubMed ID: 38426107
[TBL] [Abstract][Full Text] [Related]
6. miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy.
Hennino MF; Buob D; Van der Hauwaert C; Gnemmi V; Jomaa Z; Pottier N; Savary G; Drumez E; Noël C; Cauffiez C; Glowacki F
Sci Rep; 2016 Jun; 6():27209. PubMed ID: 27264483
[TBL] [Abstract][Full Text] [Related]
7. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy.
Bharti N; Agrawal V; Kamthan S; Prasad N; Agarwal V
Int Urol Nephrol; 2023 Jun; 55(6):1557-1564. PubMed ID: 36648741
[TBL] [Abstract][Full Text] [Related]
8. A Pilot Study to Predict Risk of IgA Nephropathy Progression Based on miR-204 Expression.
Pawluczyk I; Nicholson M; Barbour S; Er L; Selvaskandan H; Bhachu JS; Barratt J
Kidney Int Rep; 2021 Aug; 6(8):2179-2188. PubMed ID: 34386667
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
[TBL] [Abstract][Full Text] [Related]
10. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
[TBL] [Abstract][Full Text] [Related]
11. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
[TBL] [Abstract][Full Text] [Related]
12. Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images.
Testa F; Fontana F; Pollastri F; Chester J; Leonelli M; Giaroni F; Gualtieri F; Bolelli F; Mancini E; Nordio M; Sacco P; Ligabue G; Giovanella S; Ferri M; Alfano G; Gesualdo L; Cimino S; Donati G; Grana C; Magistroni R
Clin J Am Soc Nephrol; 2022 Sep; 17(9):1316-1324. PubMed ID: 35882505
[TBL] [Abstract][Full Text] [Related]
13. The increased miRNA-150-5p expression of the tonsil tissue in patients with IgA nephropathy may be related to the pathogenesis of disease.
Xu Y; He Y; Hu H; Xu R; Liao Y; Dong X; Song H; Chen X; Chen J
Int Immunopharmacol; 2021 Nov; 100():108124. PubMed ID: 34600394
[TBL] [Abstract][Full Text] [Related]
14. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H
Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814
[TBL] [Abstract][Full Text] [Related]
15. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
Fan Q; Lu R; Zhu M; Yan Y; Guo X; Qian Y; Zhang L; Dai H; Ni Z; Gu L
Nephron; 2019; 142(3):195-207. PubMed ID: 30808829
[TBL] [Abstract][Full Text] [Related]
16. Detection of microRNA-33a-5p in serum, urine and renal tissue of patients with IgA nephropathy.
Liu L; Duan A; Guo Q; Sun G; Cui W; Lu X; Yu H; Luo P
Exp Ther Med; 2021 Mar; 21(3):205. PubMed ID: 33500698
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
Yoon SY; Kim JS; Jung SW; Kim YG; Hwang HS; Moon JY; Lee SH; Seo JW; Seok J; Tae D; Jeong K
Sci Rep; 2023 Oct; 13(1):17201. PubMed ID: 37821628
[TBL] [Abstract][Full Text] [Related]
18. Plasma microRNA signature of patients with IgA nephropathy.
Wu J; Zhang H; Wang W; Zhu M; Qi LW; Wang T; Cheng W; Zhu J; Shan X; Huang Z; Zhang L; Chen Y; Sun B; Zhao X; Qian J; Zhu W; Zhou X; Xing C
Gene; 2018 Apr; 649():80-86. PubMed ID: 29459010
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Progression in IgA Nephropathy in Childhood.
Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
[TBL] [Abstract][Full Text] [Related]
20. Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.
Haaskjold YL; Lura NG; Bjørneklett R; Bostad L; Bostad LS; Knoop T
Nephrol Dial Transplant; 2023 May; 38(5):1183-1191. PubMed ID: 35904322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
